Osborne Clarke advised Creo Medical Group Plc on the deal. Creo Medical Group PLC, an AIM-quoted medical devices company focusing on the emerging field of surgical...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Creo Europe on the deal. Micro-Tech Nanjing, a Chinese producer of minimally invasive medical devices, acquired a controlling stake (51%) of Creo Medical...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Creo Medical Group PLC. Creo Medical Group PLC (” Creo “), an AIM-quoted medical devices company focusing on the emerging field of...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Creo Medical Group on the deal. Creo Medical Group, a medical device company focused on the emerging field of surgical endoscopy, quoted...
You must be a Standard 1 Year member to access this content.
